CMS Open Payments · Program Year 2024
Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging Inc. reported $14,562.50 across General Payments, Research, and Ownership to 3 physicians and teaching hospitals across 3 transactions.
- $14.6K
- All-tracks total
- 3
- Transactions
- 3
- Recipients
- #1585
- of 1,925 companies
Circle Cardiovascular Imaging Inc. reported $14,562.50 across all CMS Open Payments tracks (General + Research + Ownership) to 3 physicians and teaching hospitals in Program Year 2024 - ranking #1585 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $14,562.50, averaging $4.9K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer circle-cardiovascular-imaging-inc Circle Cardiovascular Imaging Inc.
$14.6K · #1585/1,925 · 0.0% industry · PY2024
- TOT $14.6K
- RANK #1585
- SHARE 0.0%
- TXN 3
- RCP 3
- CAT 1
- GEN $14.6K
- TOP1 48.5%
- PY 2024
Volume peers
Nearest volume peer: North American Rescue, LLC ($14.6K)
Circle Cardiovascular Imaging Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Circle Cardiovascular Imaging Inc.
Averaging $4.9K per transaction and $4.9K per recipient, Circle Cardiovascular Imaging Inc.'s Program Year 2024 total comes to $14,562.50 across 3 transactions and 3 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1585 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Consulting Fee" leads the 1-category general-payment breakdown below at $14.6K (100.0% of General Payments, 3 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Consulting Fee" leads Circle Cardiovascular Imaging Inc.'s 1-category general-payment breakdown at $14.6K, 100.0% of the reported total.
How Circle Cardiovascular Imaging Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $14.6K | 3 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $14,562.50 (100.0%) of $14,562.50 in this company's General Payments records across 3 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Circle Cardiovascular Imaging Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Paul Connor
$7,062.50 across 1 reported transactions
- 2
Kenneth Eric Stone
$3,750.00 across 1 reported transactions
- 3
Kevin Erik Steel
$3,750.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Circle Cardiovascular Imaging Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Circle Cardiovascular Imaging Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Circle Cardiovascular Imaging Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Retropsoas Technologies, LLC
Kub Technologies Inc.
Celltrion Healthcare Canada Ltd.
Medela AG
Aytu BioPharma, Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.